|
Crystal Research and Technology |
Cryst. Res. Technol. 35 (2000)
343 - Abstract -
Y. Hayakawa, K. L. Kirk, H. Kimoto*
Laboratory of Bioorganic Chemistry; National Institute of Diabetes, and Digestive and Kidney Diseases; National Institutes of Health; Bethesda, Maryland, USA
*Department of Chemistry, National Industrial Research Institute of Nagoya, Japan
Crystal and Molecular Structure of 6-Methyl-2-(trifluoromethyl)-(6H)-imidazo[1,2-c]pyrimidin-5-one
The title compound (C8H6F3N3O) crystallizes as colorless plates, triclinic, a = 10.916(2) Å, b = 11.140(1) Å, c = 8.368(1) Å, α = 95.938(9)°, β = 105.24(1)°, γ = 64.843(9)°, V = 888.6(2) Å3, Z = 4, Dcalc = 1.623g/cm3, space group P1 . The structure was solved by direct methods and refined by the full-matrix least-squares method (Rw = 0.047).
Keywords: crystal structure, imidazo[1,2-c]pyrimidine, trifluoromethyl, cycloaddition, cytosine, bromoacetoxime
The full text of this paper in pdf-Format: 
If you came directly to this page, click this symbol
to go to the homepage of CRT.